Financhill
Back

Regeneron Pharmaceuticals Stock Predictions

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks

Click Here to Download Your FREE Stock Report Now
Sell
44

REGN
Regeneron Pharmaceuticals

Last Price:
$547.36
Seasonality Move:
8.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Slow Market? Try This Instead

See how it works now.

Regeneron Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 28.7% based on the past 34 years of stock performance.
  • Regeneron Pharmaceuticals has risen higher in 21 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.76%
  • Is Regeneron Pharmaceuticals Stock Undervalued?
    The current Regeneron Pharmaceuticals [REGN] share price is $547.36. The Score for REGN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Regeneron Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 28.7% based on the past 34 years of stock performance.

Regeneron Pharmaceuticals Stock Rating

Sell
44
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals overpriced?

  • Regeneron Pharmaceuticals has risen higher in 21 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.76%

Regeneron Pharmaceuticals Stock Price History

Is REGN stock going to rise?

  • The current trend is relatively stagnant and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com

52-Week Data

52-Week High:
1,211.20
52-Week Low:
476.49

Prediction Charts

Market Cap:
59.1B
Price in USD:
547.36
Volume:
456.4K
Beta:
0.94

Technical Analysis

SMA50:
552.25
SMA100:
600.16
SMA200:
721.27
52-Wk Change:
-46.55%

Stock Predictions

  • Is Regeneron Pharmaceuticals stock public?
    Yes, Regeneron Pharmaceuticals is a publicly traded company.
  • What is the Regeneron Pharmaceuticals stock quote today?
    The Regeneron Pharmaceuticals stock price is 547.36 USD today.
  • How to buy Regeneron Pharmaceuticals stock online?
    You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 518.25 529.24 529.55 514.98
Jun-16 532.88 522.68 538.20 520.22
Jun-17 519.27 508.86 523.01 508.70
Jun-18 508.51 513.58 519.17 503.25
Jun-20 521.05 509.72 521.31 506.38
Jun-23 510.00 511.92 516.18 507.61
Jun-24 515.79 522.27 527.45 515.79
Jun-25 521.40 520.29 525.63 516.99
Jun-26 520.00 521.00 524.52 514.79
Jun-27 521.79 521.00 531.21 517.39
Jun-30 520.21 525.00 526.08 518.90
Jul-1 523.97 534.91 548.04 521.00
Jul-2 533.66 547.74 551.50 529.69
Jul-3 547.75 547.36 555.00 546.61

Regeneron Pharmaceuticals Earnings

Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Regeneron Pharmaceuticals Forecast Revenue Growth

Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $2.15 per share, an increase next quarter of $0.68 per share, a decrease this year of $9.47 per share, and an increase next year of $4.28 per share.

* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.